Literature DB >> 6336972

Anaplastic myeloma with massive extramedullary involvement. Report of two cases.

K Foucar, M Raber, E Foucar, B Barlogie, C M Sandler, R Alexanian.   

Abstract

Two patients developed anaplastic myeloma associated with prominent extramedullary disease one and four years after the initial diagnosis of multiple myeloma. Most tumor cells in the extramedullary sites were primitive-appearing and anaplastic, although plasmacytoid differentiation was evident. One patient had concurrent bone marrow involvement by cytologically similar cells, while the other patient was in bone marrow remission when he developed clinically evident soft tissue infiltration. Immunoperoxidase staining showed similar cytoplasmic immunoglobulin in both the mature-appearing and anaplastic cells in both patients. Electron microscopy in both cases showed a morphologic spectrum between the mature-appearing and anaplastic cells. DNA flow cytometric studies following the onset of extramedullary disease revealed a tumor cell population with a high degree hyperdiploid abnormality and unusually high proliferative activity in both cases, consistent with the morphologic anaplasia. Anaplastic myeloma appears to represent a distinct, aggressive variant of multiple myeloma which may result from a transformation of well differentiated myeloma cells to poorly differentiated immunoblast-like cells.

Entities:  

Mesh:

Year:  1983        PMID: 6336972     DOI: 10.1002/1097-0142(19830101)51:1<166::aid-cncr2820510132>3.0.co;2-7

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  11 in total

1.  Anaplastic myeloma: a morphologic diagnostic dilemma.

Authors:  Seema Rao; Rakhee Kar; Hara Prasad Pati
Journal:  Indian J Hematol Blood Transfus       Date:  2009-01-11       Impact factor: 0.900

2.  Vertebral osteoporosis--the importance of serum and urine electrophoresis.

Authors:  R A Hughes; C Costello; A C Keat
Journal:  Ann Rheum Dis       Date:  1994-02       Impact factor: 19.103

3.  Bulky extramedullary plasmacytomata: rare mode of relapse in myelomatosis.

Authors:  S V Davies; B Jones; C M Starkie; J A Murray
Journal:  J Clin Pathol       Date:  1989-03       Impact factor: 3.411

4.  Atypical progression of multiple myeloma with extensive extramedullary disease.

Authors:  S N Jowitt; A Jacobs; P A Batman; D A Sapherson
Journal:  J Clin Pathol       Date:  1994-03       Impact factor: 3.411

5.  Sustained remission and reversal of end-organ dysfunction in a patient with anaplastic myeloma.

Authors:  Mridul Agrawal; Jennifer Kanakry; Christina A Arnold; Daniel L Suzman; Luckson Mathieu; Yvette L Kasamon; Douglas E Gladstone; Richard F Ambinder; Nilanjan Ghosh
Journal:  Ann Hematol       Date:  2014-07       Impact factor: 3.673

6.  Anaplastic myeloma in systemic lupus erythematosus.

Authors:  R C Butler; S M Thomas; J M Thompson; A C Keat
Journal:  Ann Rheum Dis       Date:  1984-08       Impact factor: 19.103

7.  Successful outcome of anaplastic multiple myeloma with lenalidomide, cyclophosphamide, and dexamethasone therapy.

Authors:  Wenjiao Tang; Yangfan Xu; Bing Xiang
Journal:  Ann Hematol       Date:  2020-09-02       Impact factor: 3.673

8.  Relapsed Extramedullary Multiple Myeloma Presenting as Bilateral Solid Perirenal Masses.

Authors:  Thomas Rau; Aya Kamaya
Journal:  Radiol Case Rep       Date:  2015-12-07

9.  Morphological Transformation of Myeloma Cells into Multilobated Plasma Cell Nuclei within 7 Days in a Case of Secondary Plasma Cell Leukemia That Finally Transformed as Anaplastic Myeloma.

Authors:  Akihito Fujimi; Yasuhiro Nagamachi; Naofumi Yamauchi; Yuji Kanisawa
Journal:  Case Rep Hematol       Date:  2017-12-21

10.  Anaplastic multiple myeloma with MYC rearrangement.

Authors:  Satoshi Ichikawa; Noriko Fukuhara; Ko Hashimoto; Fumiyoshi Fujishima; Ryo Ichinohasama; Hideo Harigae
Journal:  Leuk Res Rep       Date:  2021-12-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.